Reuters logo
BRIEF-Cadila Healthcare says Zydus gets final USFDA approval for diflunisal tablets
June 20, 2017 / 5:24 AM / 4 months ago

BRIEF-Cadila Healthcare says Zydus gets final USFDA approval for diflunisal tablets

June 20 (Reuters) - Cadila Healthcare Ltd:

* Says Zydus gets final approval from USFDA for diflunisal tablets

* Drug is a nonsteroidal anti-inflammatory drug; will be produced at group's formulations manufacturing facility at Baddi Source text: (bit.ly/2sNemKR) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below